Peer-led HIV prevention choices for women at high risk in Uganda
Peer-led Dynamic Choice HIV Prevention for Women at Elevated HIV Risk in Uganda
This program helps women at higher risk of HIV in Uganda work with peer supporters to choose and keep using prevention options like pills, long‑acting injections, or a vaginal ring.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11509060 on NIH RePORTER |
What this research studies
You would be connected with trained peers who explain different HIV prevention options and support your choice, including switching products over time. The program offers a choice of getting services at a clinic or in community locations and includes training for providers to be more helpful. The team builds on earlier trials that doubled the time women were covered by prevention products but now focuses on reaching women who were missed before. The activities include outreach, shared decision conversations, and follow‑up to help people stay on the prevention that fits their life.
Who could benefit from this research
Good fit: Ideal candidates are HIV‑negative women in Uganda who face elevated HIV risk (for example, venue‑based workers) and want support choosing and using biomedical prevention options.
Not a fit: People living with HIV, men, or people who do not live in the participating Ugandan communities are unlikely to benefit from this prevention program.
Why it matters
Potential benefit: If successful, this approach could help more women stay protected from HIV by making prevention easier to choose and use where they live and work.
How similar studies have performed: Previous randomized trials of the Dynamic Choice approach increased time covered by a prevention product more than twofold, showing promising results though gaps in reaching some high‑risk women remain.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Koss, Catherine Anne Stimets — University of California, San Francisco
- Study coordinator: Koss, Catherine Anne Stimets
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.